PDLB Q4 2025 Earnings Significant EPS Beat Belies Stock Decline XMTR Q1 2026 Earnings EPS Beat Drives Mild Stock Uptick Ocular Therapeutix Q1 2026 Earnings EPS Misses Estimates as RD Investments Continue NVS Q1 2026 Earnings EPS Falls Short by 85 But Stock Holds Steady AVTR Q1 2026 Earnings EPS Beats Estimates Stock Rises SEE Q4 2025 Earnings EPS Surpasses Estimates by 43 Revenue Details Remain Undisclosed